Targeted Therapies in Oncology
December II 2025
Volume: 14
Issue: 16
December I 2025
Volume: 14
Issue: 15
November 2025
Volume: 14
Issue: 14
October 2025
Volume: 14
Issue: 13
September II 2025
Volume: 14
Issue: 12
September I 2025
Volume: 14
Issue: 11
August 2025
Volume: 14
Issue: 10
July 2025
Volume: 14
Issue: 9
June II 2025
Volume: 14
Issue: 8
June I 2025
Volume: 14
Issue: 7
May I 2025
Volume: 14
Issue: 6
April I 2025
Volume: 14
Issue: 5
March II 2025
Volume: 14
Issue: 4
March I 2025
Volume: 14
Issue: 3
February I, 2025
Volume: 14
Issue: 2
January I 2025
Volume: 14
Issue: 1
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
3
Pelareorep Offers Promise in Second-Line KRAS-Mutant Metastatic CRC
4
Phase 3 Data Highlight Orca-T’s Clinical Benefits in Heme Malignancies
5